News News

Kuancheng and his gastrointestinal motility instrument appeared in the "Latest Consensus of Primary Digestive System Diseases and Digestive Endoscopy Summit Forum"

Date: 2020-12-22
Views: 84

  From December 18 to 19, 2020, the first 'Summit Forum on the Latest Consensus and Digestive Endoscopy of Primary Digestive Diseases' was held in Nanjing Hospital (Nanjing First Hospital) affiliated to Nanjing Medical University. The meeting focused on the development of gastrointestinal microecology, early diagnosis and treatment of digestive system tumors, biliary and pancreatic diseases, liver diseases, minimally invasive technology of digestive endoscopy and other fields.


  The meeting invited many experts to participate in the interpretation and discussion of the latest consensus in the field of digestive endoscopy, display the latest diagnosis and treatment technologies and research achievements in the field of digestive endoscopy, and give excellent lectures on the latest diagnosis and treatment progress in the field of digestive endoscopy. It aims to improve the diagnosis and treatment of common digestive diseases in primary medical institutions.


  Nanjing Kuancheng Technology Co., Ltd. appeared at this forum with the core product 'Biofeedback Gastrointestinal Dynamometer' independently developed by the enterprise, which attracted wide attention from the guests.



  The biofeedback gastrointestinal motility instrument is independently developed by Nanjing Kuancheng Technology Co., Ltd., based on the 'gastrointestinal pacing theory', focusing on the detection and treatment equipment in the field of digestion. The technology is leading, and has obtained a number of national patents and computer software copyrights. After many years of clinical trials, the total effective rate of its treatment for 'functional constipation, postprandial discomfort syndrome, nausea and vomiting after radiotherapy and chemotherapy of tumors' is more than 80%.

Related Content
On the evening of August 18, 2022, Kuancheng Technology held a symposium on gastrointestinal motility. The theme of the conference was 'Application of gastrointestinal motility detection and treat...
2022 - 08 - 19
Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disease characterized by abdominal pain, abdominal distension and abdominal discomfort accompanied by changes in defecation habi...
2022 - 07 - 15
'Salt therapy' was recommended by the latest Chinese Expert Consensus on Pneumoconiosis and Lung Rehabilitation!Xinashu rock salt aerosol therapy - a new scheme for lung rehabilitation of pneu...
2022 - 07 - 14
On May 26, 2022, Jiang Wei, deputy director of Jiangsu Drug Administration, visited our company (Nanjing Kuancheng Technology Co., LTD.) to carry out special research on the review and approval of Cla...
2022 - 05 - 27
Functional gastrointestinal diseases, accounting for more than 50% of gastroenterology outpatients. Such as abdominal bloating or flatulence, loss of appetite, early satiety, heartburn, hiccups, belch...
2022 - 05 - 25
(National Service Hotline)
Copyright ©2018 - 2023 Nanjing Kuancheng Technology Co., Ltd
Be lenient towards others and be honest
Share to WeChat friends circle ×
Open WeChat and click "Discovery" at the bottom,
Use "Scan" to share pages with your friends.
Follow us: